DART Disclosure
- Hanmi's Q2 Operating Profit More Than Doubles on 29% Sales Jump
Hanmi Pharm posted Q2 revenue of 467.2 billion won and operating profit of 131 billion won, with margins widening to 28% from about 17% a year earlier.
- Five KOSDAQ Firms Approve Third-Party Share Sales in a Single Day
On July 6, five KOSDAQ-listed companies disclosed third-party allocation rights offerings totaling about 74 billion won, signaling a burst of private placement
